Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Xu, Xiaohong  [Clear All Filters]
2024
Liu X, Wang F, Fan X, Chen M, Xu X, Xu Q, Zhu H, Xu A, Pouladi MA, Xu X. CHCHD2 up-regulation in Huntington disease mediates a compensatory protective response against oxidative stress. Cell Death Dis. 2024;15(2):126.
2023
Chen Z, Chen J, Xu X, Li Q, Zhang C, Li S, Liu L, Cao C, Chen D, He Q. METTL3-mediated ALDH m A methylation regulates the malignant behavior of BMI1 HNSCC stem cells. Oral Dis. 2023.
2020
Wright GEB, Caron NS, Ng B, Casal L, Casazza W, Xu X, Ooi J, Pouladi MA, Mostafavi S, Ross CJD, et al. Gene expression profiles complement the analysis of genomic modifiers of the clinical onset of Huntington disease. Hum Mol Genet. 2020.
2019
Si L, Yang R, Liu J, Dong Y, Zhang H, Xu X. Generation of two ERF gene knockout human embryonic stem cell lines using CRISPR/Cas9 system. Stem Cell Res. 2019;41:101644.
Ooi J, Langley SR, Xu X, Utami KH, Sim B, Huang Y, Harmston NP, Tay YLin, Ziaei A, Zeng R, et al. Unbiased Profiling of Isogenic Huntington Disease hPSC-Derived CNS and Peripheral Cells Reveals Strong Cell-Type Specificity of CAG Length Effects. Cell Rep. 2019;26(9):2494-2508.e7.
2016
Li J, Ma J, Meng G, Lin H, Wu S, Wang J, Luo J, Xu X, Tough D, Lindon M, et al. BET bromodomain inhibition promotes neurogenesis while inhibiting gliogenesis in neural progenitor cells. Stem Cell Res. 2016;17(2):212-221.